PMH25 A COMPARISON OF THE COST-EFFECTIVENESS OF OLANZAPINE FOR THE TREATMENT OF SCHIZOPHRENIA IN SELECTED NON-OECD COUNTRIES
Abstract
Authors
P Davey N Price M Lees L Birinyi-Strachan K Makino M Mudge
P Davey N Price M Lees L Birinyi-Strachan K Makino M Mudge
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now